| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000012940 |
| Receipt No. | R000015138 |
| Scientific Title | Gene mutation analysis such as FGF signaling in gastrointesitinal cancer |
| Date of disclosure of the study information | 2014/01/24 |
| Last modified on | 2022/08/01 (Ver. 4) |
| Basic information | ||
| Public title | Gene mutation analysis such as FGF signaling in gastrointesitinal cancer | |
| Acronym | Gene mutation analysis such as FGF signaling in gastrointesitinal cancer | |
| Scientific Title | Gene mutation analysis such as FGF signaling in gastrointesitinal cancer | |
| Scientific Title:Acronym | Gene mutation analysis such as FGF signaling in gastrointesitinal cancer | |
| Region |
|
|
| Condition | |||||
| Condition | Cancer of digestive organs | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | YES | ||||
| Objectives | |
| Narrative objectives1 | To analyse gene mutation such as Fibroblast Growth Factor (FGF) signaling in cancer of digestive organs. |
| Basic objectives2 | Others |
| Basic objectives -Others | Analysisi of gene mutation and location in cancer of digestive organs. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Incidence and location of gene mutation such as FGF-FGFR signaling in cancer of digestive organs. |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with cancer in digestive organs (esophageal, gastric , biliary, pancreatic) whose paraffin-embedded samples by biopsy, endoscopic resection or surgery were obtained at St Marianna University School of Medicine Hospital . | |||
| Key exclusion criteria | None | |||
| Target sample size | 500 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | St. Marianna University School of Medicine | ||||||
| Division name | Department of Clinical Oncology | ||||||
| Zip code | |||||||
| Address | 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa | ||||||
| TEL | 0449778111 | ||||||
| tnakajima@marianna-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | St. Marianna University School of Medicine | ||||||
| Division name | Department of Clinical Oncology | ||||||
| Zip code | |||||||
| Address | 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa | ||||||
| TEL | 0449778111 | ||||||
| Homepage URL | |||||||
| tnakajima@marianna-u.ac.jp | |||||||
| Sponsor | |
| Institute | St. Marianna University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | St. Marianna University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Kinki University School of Medicine, Department of Genome Biology |
| Name of secondary funder(s) | Kinki University School of Medicine, Department of Genome Biology |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Gene mutation analysis:
1. Gene mutation of FGF-FGFR pathway 2. Any new candidates of biomarker |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015138 |